Search
Displaying 621–630 of 663 for “retinitis clinical trial”
-
ARVO 2019: Emerging Eloxx Molecules Show Promising Results in Usher Models
Research NewsEloxx Pharmaceuticals is developing small molecules that permit read-through of point mutations that cause Usher syndrome 1F and 2A.
-
Find out where your donation dollars go.
-
About Page
Roster of the Foundation Fighting Blindness Scientific Advisory Board
-
Subsription Management Page
-
Sign up to receive email updates from FFB
-
Disease
X-linked retinoschisis (XLRS) is an inherited retinal diseasing causing vision loss due to splitting of the layers of the retina.
-
The following list of doctors has been compiled by the Foundation Fighting Blindness for the convenience of patients and families. The accuracy of the list cannot be guaranteed nor should it be construed as an endorsement of any doctor.
-
Beacon Stories
Kai Wang was 18 months old when he was diagnosed with the condition. His parents never imagined the extraordinary journey they would take with their son when they learned he had a condition that would render him blind.
